More about Sun Pharmaceutical Industries Limited
Fundamentals for Sun Pharmaceutical Industries Limited
Regulatory Filings for Sun Pharmaceutical Industries Limited
Why Oman Is Now India's Most Strategic Trade Partner
Infrastructure Bet Fuels Cement Surge
Apollo FY26: When Healthcare Becomes a Flywheel
NITI Blueprint Could Turn Brain Drain Into $135Bn Engine
Technicals for Sun Pharmaceutical Industries Limited
Price Summary
Sun Pharmaceutical Industries Limited's stock opened at 1781.0 on 2026-06-03, surged to 1796.3, dropped to 1756.8, and ended 0.42% higher at 1788.5, with 4209674 shares traded.The stock's highest value over the last 52 weeks is 1905.8, and the lowest value is 1563.3.
Technicals
Support and Resistance: At 1788.5, the price is supported by 1785.5 and resisted by 1825.9. This indicates that the price for Sun Pharmaceutical Industries Limited might fluctuate between these levels, with 1785.5 acting as a support and 1825.9 limiting further upward movement.Aroon: The Aroon indicator shows a continued bearish trend, with Aroon Down remaining at 100. This indicates strong downward momentum, but to understand the full implications, the trend should be examined alongside other technical indicators.
Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
Parabolic SAR: The PSAR maintains a bearish stance, establishing a resistance level that could act as a barrier to any upward trends. This ongoing bearish outlook suggests that the market may continue to face resistance, keeping prices in check.
Stochastic: The K-line has crossed above the D-line on the stochastic indicator while staying under 20, indicating a potential bullish move. This pattern is often viewed as an early sign that the market might begin to climb from a low level. Traders may consider this a favorable opportunity for a buying strategy.
Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral stance, not indicating a clear upward or downward trend for Sun Pharmaceutical Industries Limited. This suggests a period of market balance, where neither side is showing dominance.
A thorough analysis of a company involves looking beyond its stock price movements and trading patterns. You must also examine its fundamentals, which include profitability, growth prospects, and competitive advantages. Additionally, the industry in which the company operates provides important context, as factors like technological innovations, regulation, and market demand influence performance. By integrating this information with technical analysis, more accurate predictions about the company's future can be made.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
RAINMUMBAI Turns Rain Into a Financial Asset
India’s IT Sector Faces a Historic Breaking Point
How Independent Directors Failed Rs 2,500 Crore in Value